About KBI Biopharma
KBI Biopharma is a company based in Durham (United States) founded in 1996 was acquired by JSR Life Sciences in February 2015. KBI Biopharma has raised $18.29 million across 5 funding rounds from investors including NCBiotech, Ballast Point Ventures and INCJ. The company has 1,243 employees as of December 31, 2021. KBI Biopharma has completed 1 acquisition, including Alliance Protein Laboratories. KBI Biopharma offers products and services including Cell Line Development, Process Development, Analytical Development, Formulation Development, and Clinical Manufacturing. KBI Biopharma operates in a competitive market with competitors including Aldevron, Kemwell Biopharma, Eurogentec, Ovagen and Laurus Bio, among others.
- Headquarter Durham, United States
- Employees 1243 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$31.68 K (USD)6as on Dec 31, 2023
-
Net Profit
-$7.46 K (USD)-203as on Dec 31, 2023
-
EBITDA
Not available
-
Total Equity Funding
$18.29 M (USD)
in 5 rounds
-
Latest Funding Round
$9.6 M (USD), Series A
Aug 14, 2009
-
Investors
NCBiotech
& 4 more
-
Employee Count
1243
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
JSR Life Sciences
(Feb 26, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KBI Biopharma
KBI Biopharma offers a comprehensive portfolio of products and services, including Cell Line Development, Process Development, Analytical Development, Formulation Development, and Clinical Manufacturing.
Development of cell lines for biopharmaceutical production processes
Creation of scalable processes for new biologic therapeutics
Comprehensive analysis and characterization of biologic molecules
Optimization of formulations for biologic stability and efficacy
GMP manufacturing for clinical-stage biopharmaceuticals
People of KBI Biopharma
Unlock access to complete
Software Development Team
60 people
Leadership Team
36 people
Senior Team
31 people
Legal and Compliance
15 people
Scientist Team
9 people
Product Management Team
8 people
Program Team
6 people
Principal Team
6 people
Unlock access to complete
Funding Insights of KBI Biopharma
KBI Biopharma has successfully raised a total of $18.29M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $9.6 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in KBI Biopharma
KBI Biopharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include NCBiotech, Ballast Point Ventures and INCJ.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Expansion capital is provided by Ballast Point Ventures to growing companies.
|
Locked | Locked | Locked | |
|
Biotech startups are incubated and funded in North Carolina.
|
Locked | Locked | Locked | |
|
Investment activities in various industries are conducted by INCJ.
|
Locked | Locked | Locked |
Investor details for KBI Biopharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KBI Biopharma
KBI Biopharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Alliance Protein Laboratories.
Investment portfolio details for KBI Biopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biophysical characterization services for proteins and macromolecules are provided.
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for KBI Biopharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - KBI Biopharma
Detailed financials for KBI Biopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kbi Biopharma Comparisons
Peer comparison for KBI Biopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KBI Biopharma
KBI Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aldevron, Kemwell Biopharma, Eurogentec, Ovagen and Laurus Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Precision fermentation services for biopharma and food are provided.
|
Detailed competitors of KBI Biopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kbi Biopharma
Complete news archive for KBI Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KBI Biopharma
KBI Biopharma was founded in 1996 and raised its 1st funding round 7 years after it was founded.
KBI Biopharma is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
KBI Biopharma is a funded company, having raised a total of $18.29M across 5 funding rounds to date.
As of Dec 31, 2021, the latest employee count at KBI Biopharma is 1,243.
Annual revenue of KBI Biopharma is $31.68K as on Dec 31, 2023.
KBI Biopharma was established in 1996 in Durham, United States, within the biopharmaceutical industry. Core operations encompass protein formulation, process and cell line development, alongside cGMP manufacturing services. These activities support biopharmaceutical clients from preclinical stages through to commercial-scale production. The company maintains its primary location in Durham, facilitating services across various global markets.
KBI Biopharma's top competitors include Aldevron, Ovagen and Omnia Biologics.
KBI Biopharma offers Cell Line Development, Process Development, Analytical Development, Formulation Development, and Clinical Manufacturing.
KBI Biopharma has made 1 acquisition, including Alliance Protein Laboratories.
KBI Biopharma has 5 investors. Key investors include NCBiotech, Ballast Point Ventures, INCJ, CMiC, and JSR Life Sciences.